About the BioMaP-Consortium
Who We Are
The Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium), established by the Biomedical Advanced Research and Development Authority (BARDA) and managed by Advanced Technology International (ATI), is a U.S. Government-supported network that serves as a shared resource for preparedness and response efforts across federal agencies. The Consortium brings together organizations from across the drug and vaccine manufacturing ecosystem, including manufacturers, suppliers of raw materials and consumables, developers of innovative manufacturing technologies, research institutions, and providers of fill-finish services.
What We Do
The BioMaP-Consortium connects organizations with relevant capabilities to support U.S. public health preparedness. The Consortium provides a structure for organizations to:
- Work together across the manufacturing ecosystem
- Participate in projects aligned with national priorities
- Build and expand capabilities over time
By bringing these organizations together, the BioMaP-Consortium helps strengthen domestic manufacturing capacity and improve the nation’s ability to respond to future health threats.
Interested in Joining?
Organizations with relevant capabilities across the vaccine and biopharmaceutical manufacturing ecosystem are encouraged to apply. Membership provides access to a network of partners, opportunities to collaborate, and visibility into efforts that support U.S. public health preparedness.